tradingkey.logo

IDEXX Laboratories Inc

IDXX
639.580USD
-5.030-0.78%
Horário de mercado ETCotações atrasadas em 15 min
70.43BValor de mercado
48.55P/L TTM

IDEXX Laboratories Inc

639.580
-5.030-0.78%

Mais detalhes de IDEXX Laboratories Inc Empresa

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.

Informações de IDEXX Laboratories Inc

Código da empresaIDXX
Nome da EmpresaIDEXX Laboratories Inc
Data de listagemJun 21, 1991
CEOEmerson (Andrew)
Número de funcionários11000
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 21
EndereçoOne Idexx Drive
CidadeWESTBROOK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal04092-2041
Telefone12075560300
Sitehttps://www.idexx.com/
Código da empresaIDXX
Data de listagemJun 21, 1991
CEOEmerson (Andrew)

Executivos da empresa IDEXX Laboratories Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+262.00%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+346.00%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
--
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.12K
+183.00%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
3.84K
+1447.00%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.00K
+262.00%
Mr. Michael Schreck
Mr. Michael Schreck
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
1.92K
+1018.00%
Mr. Bruce L. Claflin
Mr. Bruce L. Claflin
Independent Director
Independent Director
1.72K
--
Ms. Irene Chang Britt
Ms. Irene Chang Britt
Independent Director
Independent Director
208.00
--
Mr. George J. Fennell
Mr. George J. Fennell
Executive Vice President - Global CAG Commercial
Executive Vice President - Global CAG Commercial
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+262.00%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+346.00%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
--
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.12K
+183.00%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
3.84K
+1447.00%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.00K
+262.00%

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
CAG Diagnostics recurring revenue
873.27M
79.01%
IDEXX VetLab consumables
387.81M
35.09%
Reference laboratory diagnostic and consulting services
362.73M
32.82%
Rapid assay products
88.64M
8.02%
CAG Diagnostics capital - instruments
87.78M
7.94%
Outro
-694.99M
-62.88%
Por RegiãoUSD
Nome
Receita
Proporção
United States
705.04M
63.79%
Europe & Middle East & Africa (EMEA) (Region)
245.06M
22.17%
Asia Pacific
90.72M
8.21%
Canada
41.38M
3.74%
Latin America
23.04M
2.08%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
CAG Diagnostics recurring revenue
873.27M
79.01%
IDEXX VetLab consumables
387.81M
35.09%
Reference laboratory diagnostic and consulting services
362.73M
32.82%
Rapid assay products
88.64M
8.02%
CAG Diagnostics capital - instruments
87.78M
7.94%
Outro
-694.99M
-62.88%

Distribuição de ações

Atualizado em: sex, 6 de fev
Atualizado em: sex, 6 de fev
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
12.41%
Elyxium Wealth, LLC
6.79%
BlackRock Institutional Trust Company, N.A.
6.56%
State Street Investment Management (US)
4.41%
Fundsmith LLP
3.27%
Outro
66.57%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
12.41%
Elyxium Wealth, LLC
6.79%
BlackRock Institutional Trust Company, N.A.
6.56%
State Street Investment Management (US)
4.41%
Fundsmith LLP
3.27%
Outro
66.57%
Tipos de investidores
Investidores
Proporção
Investment Advisor
60.41%
Investment Advisor/Hedge Fund
30.64%
Research Firm
3.98%
Pension Fund
3.21%
Bank and Trust
1.89%
Individual Investor
0.69%
Sovereign Wealth Fund
0.59%
Hedge Fund
0.50%
Family Office
0.45%

Participação acionária institucional

Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
2411
81.21M
101.70%
-691.60K
2025Q3
2319
77.76M
97.19%
-4.03M
2025Q2
2277
79.81M
99.73%
-1.01M
2025Q1
2279
79.02M
98.21%
-512.23K
2024Q4
2242
76.14M
93.59%
-5.30M
2024Q3
2152
77.90M
94.66%
-4.67M
2024Q2
2140
80.09M
96.98%
-924.14K
2024Q1
2154
77.56M
93.40%
-2.57M
2023Q4
2187
77.94M
93.84%
-2.83M
2023Q3
2153
79.23M
95.34%
-677.16K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
9.93M
12.43%
+85.73K
+0.87%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
5.24M
6.56%
-65.11K
-1.23%
Sep 30, 2025
State Street Investment Management (US)
3.52M
4.41%
-36.75K
-1.03%
Sep 30, 2025
Fundsmith LLP
2.61M
3.27%
-28.83K
-1.09%
Sep 30, 2025
Geode Capital Management, L.L.C.
2.50M
3.13%
+33.39K
+1.35%
Sep 30, 2025
Baron Capital Management, Inc.
1.88M
2.36%
-148.49K
-7.31%
Sep 30, 2025
Invesco Capital Management (QQQ Trust)
1.79M
2.24%
+114.65K
+6.84%
Dec 31, 2025
Polen Capital Management, LLC
1.13M
1.41%
-68.28K
-5.71%
Sep 30, 2025
Walter Scott & Partners Ltd.
1.12M
1.4%
+360.23K
+47.61%
Sep 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: ter, 2 de dez
Atualizado em: ter, 2 de dez
Nome
Proporção
ProShares Pet Care ETF
9.4%
iShares U.S. Medical Devices ETF
4.42%
First Trust Water ETF
3.98%
SMI 3Fourteen Full-Cycle Trend ETF
3.9%
Nuveen ESG Mid-Cap Growth ETF
3.47%
Adaptive Core ETF
2.61%
First Trust S&P 500 Economic Moat Index ETF
2.25%
Acruence Active Hedge US Equity ETF
2.18%
Tema Durable Quality ETF
2.1%
Putnam Sustainable Future ETF
2.03%
Ver Mais
ProShares Pet Care ETF
Proporção9.4%
iShares U.S. Medical Devices ETF
Proporção4.42%
First Trust Water ETF
Proporção3.98%
SMI 3Fourteen Full-Cycle Trend ETF
Proporção3.9%
Nuveen ESG Mid-Cap Growth ETF
Proporção3.47%
Adaptive Core ETF
Proporção2.61%
First Trust S&P 500 Economic Moat Index ETF
Proporção2.25%
Acruence Active Hedge US Equity ETF
Proporção2.18%
Tema Durable Quality ETF
Proporção2.1%
Putnam Sustainable Future ETF
Proporção2.03%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI